Beijing, China

Heng Xu

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 6.5

ph-index = 1


Company Filing History:


Years Active: 2018-2025

where 'Filed Patents' based on already Granted Patents

4 patents (USPTO):

Title: **Innovations by Heng Xu: Pioneering Patents in Pharmaceutical Composition**

Introduction

Heng Xu, an accomplished inventor based in Beijing, China, has made significant contributions to the field of pharmaceuticals with a portfolio of four patents. His innovative work primarily focuses on compounds that have the potential to treat a variety of diseases by targeting specific biological pathways.

Latest Patents

Among Heng Xu's latest patents is a groundbreaking invention titled "Benzamide compound and preparation method, use, and pharmaceutical composition thereof." This patent details a benzamide compound represented by a specific formula, which acts as a STAT3 inhibitor. This compound holds promise for the prevention and treatment of diseases related to STAT3 activity, including tumors, autoimmune disorders, renal diseases, cardiovascular conditions, inflammation, metabolic dysfunctions, and neurological diseases.

Additionally, he has developed another significant patent for "Quinazoline compounds, preparation method, use, and pharmaceutical composition thereof." This invention introduces quinazoline compounds, also represented by a designated formula, that serve as phosphatidylinositol 3-kinase (PI3K) inhibitors. These compounds are aimed at treating diseases associated with PI3K activity, which encompasses cancer, immune diseases, cardiovascular issues, viral infections, inflammation, and various metabolic and neurological disorders.

Career Highlights

Heng Xu's career is marked by his association with prestigious institutions such as the Chinese Academy of Sciences and Peking University. His work at these institutions has allowed him to engage in cutting-edge research and development, culminating in the patents that underscore his contributions to medical science.

Collaborations

Part of Heng Xu's success can be attributed to his collaborative efforts with notable coworkers, including Songwen Lin and Xiaoguang Chen. Together, they have worked on various research projects that leverage their collective expertise in pharmaceutical sciences.

Conclusion

Heng Xu stands out as a leading inventor in the realm of pharmaceutical innovations, with his patents contributing to important advancements in healthcare. His work not only reflects his dedication to addressing pressing medical issues but also exemplifies the significant impact of research and collaboration in the field. With continued focus on innovative solutions, Heng Xu's future endeavors are likely to further enhance therapeutic options for numerous diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…